[Xanthogranulomatous pyelonephritis. Our experience and review of the literature]

[Xanthogranulomatous pyelonephritis. Our experience and review of the literature] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Xanthogranulomatous pyelonephritis. Our experience and review of the literature] Abstract Text:

BACKGROUND: Ten cases of xanthogranulomatous pyelonephritis (XGP) with diagnostic and therapeutic observation are described and other experiences reported in the literature are analyzed. METHODS: The clinical, laboratory and radiological features of 10 patients who had undergone nephrectomy in our Istitute, between October 1993 and March 2000, with a postoperative pathological diagnosis of XGP have been retrospectively re-evaluated. RESULTS: The most frequent symptom was flank pain. All the patients presented leucocytosis. Urine culture was positive for Proteus Mirabilis in four patients (40%) and for E. Coli in three (30%). In all the patients an ultrasound scan and urography were performed, six patients (60%) had undergone a CT scan and two of them (20%) a MRI. In six patients (60%) urinary lithiasis was associated and it was ramified in four of them (40%). The disease was always unilateral, affecting the right kidney in six cases and the left one in the other four. In three cases (30%) it presented in the focal form. The treatment was always surgical and it consisted of nephrectomy; a conservative surgical approach was used in two cases (20%). At the follow-up 4 patients (40%) showed recurrent urinary tract infections. None presented relapse. CONCLUSIONS: XGP is an uncommon chronic inflammatory disease, often associated with urinary tract infections and/or urolithiasis. The clinical presentation is nonspecific so that differential diagnosis with other kidney diseases becomes difficult. A CT scan can be helpful in formulating diagnosis. The treatment is surgical and it consists of a nephrectomy, while a conservative approach can be reserved in some cases for the focal form. Cases treated with antibotics have been described.

[Xanthogranulomatous pyelonephritis. Our experience and review of the literature] Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

[Xanthogranulomatous pyelonephritis. Our experience and review of the literature] Journal Published:

PUBLICATION TYPE: Review

Journal: Minerva urologica e nefrologica = The Italian jour

VOLUME: 52

Page Numbers: 173-8

Journal Abbreviation: Minerva Urol Nefrol

ISSN: 0393-2249

DAY: 23

MONTH: Dec

YEAR: 2000

[Xanthogranulomatous pyelonephritis. Our experience and review of the literature] Information

Number of References: 16

LANGUAGE: ita

NlmUniqueID: 8503649

[Xanthogranulomatous pyelonephritis. Our experience and review of the literature] Keywords Mesh Terms:

KEYWORDS: Retrospective Studies

MESH TERMS: therapy

Chemical & Substance for Abstract: [Xanthogranulomatous pyelonephritis. Our experience and review of the literature] Information

Substance Name:

Registry Number:

Grant and Affiliation Information for [Xanthogranulomatous pyelonephritis. Our experience and review of the literature]

AFFILIATION: Servizio di Endourologia, Clinica Urologica, Università degli Studi Federico II, Napoli.

Country: Italy

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Minerva Urol Nefrol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Xanthogranulomatous pyelonephritis Our experience and review of the literature Related Publications

• A mathematical formula to estimate in vivo thyroid volume from two-dimensional ultrasonography.
• A new transportable shock-wave lithotripsy machine for managing urinary stones: a single-centre experience with a dual-focus lithotripter.
• Analysis of clinical, ultrasound and colour flow-Doppler characteristics in predicting malignancy in follicular thyroid neoplasms.
• Beneficial effects of low doses of red wine consumption on perturbed shear stress-induced atherogenesis.
• Bipolar plasmakinetic technology for the treatment of symptomatic benign prostatic hyperplasia: evidence beyond marketing hype?
• Bone growth retardation in mouse embryos expressing human collagenase 1.
• Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study.
• Emerging role of MAP kinase pathways as therapeutic targets in COPD.
• Expression of HECA-452 antigen correlates with disease relapse in mycosis fungoides.
• Impaired bone fracture healing in matrix metalloproteinase-13 deficient mice.
• Iodine deficiency in pregnant women residing in an area with adequate iodine intake.
• Joint diseases and matrix metalloproteinases: a role for MMP-13.
• Loss of MMP-13 Delays Inflammatory Response after Acute Hyperoxic Lung Injury.
• Modified Supine versus Prone Position in Percutaneous Nephrolithotomy for Renal Stones Treatable with a Single Percutaneous Access: A Prospective Randomized Trial.
• Neuroendocrine differentiation after neoadjuvant hormonal treatment in prostate cancer.
• The estimation of the thyroid volume before surgery-an important prerequisite for minimally invasive thyroidectomy.
• The pharmokinetic limitations of antioxidant treatment for COPD.
• Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model.
• Transgenic expression of matrix metalloproteinase-9 causes adult-onset emphysema in mice associated with the loss of alveolar elastin.
• [Xanthogranulomatous pyelonephritis. Our experience and review of the literature]